|
Categories
Pharmaceutical Company
Pharmaceutical Sales
Pharmaceutical
Distributor
Pharmaceutical
Preparation
Pharmaceutical
Jobs
Pharmaceutical
Industry
Pharmaceutical
Drug
Pharmaceutical
Sales Jobs
Pharmaceutical
Product
Pharmaceutical
News
Pharmaceutical
Research
Pharmaceutical
Manufacturer
Pharmaceutical Sales
Rep
Pharmaceutical
Sales Resume
Pharmaceutical
Online
Pharmaceutical
Marketing
Pharmaceutical
Dictionary
Pharmaceutical
Recruiter
Pharmaceutical
Supply
Pharmaceutical
Technology
Pharmaceutical
Advertising
Pharmaceutical
Schools
Companies
Pfizer Pharmaceutical
Wyeth Pharmaceutical
Watson Pharmaceutical
Merck Pharmaceutical
Roche Pharmaceutical
King Pharmaceutical
Teva Pharmaceutical
Aventis
Pharmaceutical
Novartis
Pharmaceutical
Forest
Pharmaceutical
Tap
Pharmaceutical
Shire
Pharmaceutical
Mayne
Pharmaceutical
Millennium
Pharmaceutical
Lilly
Pharmaceutical
Mylan
Pharmaceutical
Kos
Pharmaceutical
Takeda
Pharmaceutical
Endo
Pharmaceutical
Janssen
Pharmaceutical
Barr
Pharmaceutical
Abbott
Pharmaceutical
Reliant
Pharmaceutical
Solvay
Pharmaceutical
Amylin
Pharmaceutical
Vertex
Pharmaceutical
Osi
Pharmaceutical
Bayer
Pharmaceutical
Voyager
Pharmaceutical
Mcneil
Pharmaceutical
Boehringer
Ingelheim
Astra
Zeneca Pharmaceutical
Glaxosmithkline
Pharmaceutical
Novo Nordisk
Pharmaceutical
3m
Pharmaceutical
Eli
Lilly Pharmaceutical
Elan Pharmaceutical
Ivax
Pharmaceutical
Search engines:
Google
Lycos
AltaVista
Yahoo
Mirago
Ask
Teoma
Excite |
|
|
|
Sanofi-Aventis Pharmaceutical
 Sanofi-Aventis
Pharmaceutical
With 2004 pro forma combined net sales ¹ of
25,418 million euros, +10.0% and an estimated 100,000 employees worldwide,
sanofi-aventis is the world’s 3rd largest pharmaceutical company and ranks
number 1 in Europe. Global headquarters are located in Paris, France and the
U.K. headquarters are in Guildford, Surrey.
Sanofi-aventis focuses its
activities on seven major therapeutic areas: cardiovascular, thrombosis,
oncology, internal medicine, metabolic disorders, diseases of the central
nervous system and vaccines.
The sanofi-aventis portfolio of marketed
products contains several medicines that are world leaders in their respective
classes including: Clexane® (enoxaparin sodium), Plavix® (clopidogrel
bisulfate), Telfast® (fexofenadine), Aprovel® (irbesartan),
Eloxatin™ (oxaliplatin), Lantus® (insulin glargine), Actonel®
(risedronate sodium) and Taxotere® (docetaxel).
Sanofi-aventis is an
industry-leading R&D organisation that is comprised of over 17,000 research
staff working in over 20 research centres around the world. Sanofi-aventis
maintains its commitment to creating innovative therapeutic treatments and has
devoted over four billion euros to its current portfolio that includes over 48
compounds presently in advanced stages of development.
Sanofi-Aventis
in the UK
Sanofi-aventis' operations in the UK reflect the
phenomenal achievements of the company worldwide.
The Sanofi-aventis
portfolio of medicines mirror the main priorities of the National Health
Service which are to: reduce mortality from heart disease; reduce mortality
from cancer; reduce mortality from suicide; reduce adult smoking rates and
tackle obesity and support people with long term conditions. Sanofi-aventis
also have an equally exciting pipeline of new drugs and are well placed to help
meet the present and future needs of patients and healthcare professionals
alike.
As in other parts of the world, Sanofi-aventis success in
discovering and developing new medicines in these key areas is underpinned by
exceptional talent and sustained high investment - Sanofi-aventis invest
heavily in research into new and effective treatments for cardiovascular
disease/thrombosis, cancer, central nervous system, metabolic disorders and
internal medicine.
Every aspect of bringing new therapies to market is
represented in the Sanofi-aventis centres in the UK, from the pre-clinical
development of new molecules through manufacture to distribution, marketing,
regulatory compliance, product education and professional support.
At
every site and in every discipline, sanofi-aventis people are energised by a
common sense of purpose, mutual respect, and responsibility to the wider
community as well as the patients and doctors they serve.
One Of The
Fastest Growing Major Pharmaceutical Companies In The UK ²
-
UK consolidated sales (calendar year 2004): 1,116 million euros ¹
-
Current market share: 6.2% ¹
- Monthly growth rate for May 05 over May
04: 4% ²
Sanofi-aventis currently employs around 3,200 people in
the UK.
Sanofi-aventis further information
www.sanofi-aventis.co.uk/
Careers at Sanofi-aventis
As one of the world’s
fastest growing global pharmaceutical companies, Sanofi-aventis have a strong
track record of investing in their people. This is one of the reasons why, in
the recently published Pharmaceutical Field 'Company, Perception, Motivation
and Satisfaction' Survey 2004, Sanofi-aventis was rated as one of the best
companies to work for by those in the industry.
Whatever your particular
field of interest, Sanofi-aventis in the UK offers a stimulating work
environment, attractive remuneration and the satisfaction of being part of an
exciting, highly motivated and successful organisation.
|
|
|
|
|
